CUSIP: 72940R102
Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,069,321
-
Share change
-
+3,546,069
-
Total reported value
-
$12,772,000
-
Put/Call ratio
-
79%
-
Price per share
-
$2.52
-
Number of holders
-
27
-
Value change
-
+$8,906,356
-
Number of buys
-
10
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2015
-
Previous quarter:
Q1 2015
Recent filing periods for CUSIP 72940R102:
Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q2 2015
As of 30 Jun 2015,
PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,069,321 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, OPPENHEIMER & CO INC, Psagot Investment House Ltd., HighTower Advisors, LLC, COWEN GROUP, INC., and VAN ECK ASSOCIATES CORP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.